Builders First Source, Other Homebuilder Stocks Rise With Catalysts Such As Mortgage Rates, The Fed, Kamala Harris Plan
Builders FirstSource Upgraded at Truist on Housing Outlook
What Makes Builders Firstsource (BLDR) an Interesting Public Leverage Buyout?
Builders FirstSource Analyst Ratings
Express News | Builders FirstSource Inc : Truist Securities Raises to Buy From Hold
Truist Financial Upgrades Builders FirstSource(BLDR.US) to Buy Rating, Announces Target Price $220
Truist Financial analyst Keith Hughes upgrades $Builders FirstSource(BLDR.US)$ to a buy rating, and sets the target price at $220.According to TipRanks data, the analyst has a success rate of 66.4%
Optimistic Buy Rating for Builders Firstsource Amid Housing Expansion and Market Recovery
CORRECTION: Homebuilder Stocks Are Trading Higher
Shares of Housing Stocks and Homebuilders Are Trading Higher. The Sector May Be on Watch Amid a Drop in Yields and as Investors Await Rate Cuts.
Builders FirstSource, Inc. (NYSE:BLDR) Shares Could Be 41% Below Their Intrinsic Value Estimate
Builders FirstSource (BLDR) Fell Due to Slower Growth in the Housing Market
Why Is Builders FirstSource (BLDR) Up 10.5% Since Last Earnings Report?
Here's How Much You Would Have Made Owning Builders FirstSource Stock In The Last 10 Years
Shares of Companies in the Broader Industrial Sector Are Trading Lower Amid Overall Market Weakness. Weakness May Be Due to August's ISM Manufacturing PMI Data Indicating an Economic Contraction.
Oppenheimer Maintains Builders FirstSource(BLDR.US) With Buy Rating, Raises Target Price to $205
Oppenheimer analyst Tyler Batory maintains $Builders FirstSource(BLDR.US)$ with a buy rating, and adjusts the target price from $190 to $205.According to TipRanks data, the analyst has a success
Express News | Builders FirstSource : Oppenheimer Raises Target Price to $205 From $190
Builders FirstSource Inc. (BLDR): Jim Cramer's Go-To Stock For Success
Peering Into Builders FirstSource's Recent Short Interest
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Cramer's Lightning Round: Builders FirstSource 'Can Go Higher'